Table 1 Physical status of HPV genome in cases and controls
Cases (%) | Controls (%) | Total number (%) | P-value | ||
|---|---|---|---|---|---|
Integrated | 15/54 (27.8) Tumour Stages: IA (N = 0) IB (N = 2) IIA (N = 0) IIB (N = 3) IIIA (N = 1) IIIB (N = 3) IV (N = 6) | Tumour Types: Adenocarcinoma (N = 4) Squamous-cell carcinoma (N = 6) Small-cell lung carcinoma (N = 5) | 3/12 (25) | 18/66 (27.3) | 0.845 |
Episomal | 3/54 (5.5) Tumour Stages: IA (N = 0) IB (N = 1) IIA (N = 0) IIB (N = 2) IIIA (N = 0) IIIB (N = 0) IV (N = 0) | Tumour Types: Adenocarcinoma (N = 0) Squamous-cell carcinoma (N = 2) Small-cell lung carcinoma (N = 1) | 0 | 3/66 (4.5) | NA |
Mixed | 36/54 (66.7) Tumour Stages: IA (N = 1) IB (N = 0) IIA (N = 4) IIB (N = 3) IIIA (N = 7) IIIB (N = 6) IV (N = 15) | Tumour Types: Adenocarcinoma (N = 5) Squamous-cell carcinoma (N = 22) Small-cell lung carcinoma (N = 9) | 9/12 (75) | 45/66 (68.2) | 0.827 |